financetom
Business
financetom
/
Business
/
NHTSA closes preliminary evaluation of front suspension failure in Tesla vehicles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NHTSA closes preliminary evaluation of front suspension failure in Tesla vehicles
Aug 14, 2024 3:35 AM

(Reuters) -The National Highway Traffic Safety Administration said on Wednesday it has closed a preliminary evaluation into 74,918 Tesla vehicles over front suspension failures.

The auto safety agency's Office of Defects Investigation had opened a probe into the issue in 2020, based on complaints alleging failure of front suspension fore links in 2015-2017 Tesla Model S and 2016-2017 Model X vehicles.

A failed fore link, a crucial component of a vehicle's suspension system could cause additional damage to other parts.

However, the agency said it closed the investigation as no instance showed that a failure of the part prevented the ability to control the vehicle in testing and reported instances of failure.

Reuters reported in December that tens of thousands of owners had experienced premature failures of suspension or steering parts since 2016, citing Tesla documents and interviews with customers and former employees.

The documents showed that the automaker sought to blame drivers for frequent failures of suspension and steering parts it has long known were defective.

"One minor crash with no injuries is associated with the 426 instances of fore link failures. A majority of the failures occurred between one to fifteen mph while parking in driveways or parking lots," the regulator said in a notice.

Tesla did not immediately respond to a request for comment on closing of the investigation.

The NHTSA said closure of the evaluation does not mean there were no safety issues, and the agency's records show that Tesla has had nine recalls in the United States for steering and suspension issues since 2018.

The Elon Musk-led EV maker had issued a consumer satisfaction bulletin in 2017 to replace the component in some vehicles made between January and May 2016, but it does not cover 75% of instances of failures identified in the investigation, NHTSA said.

It recommended that Tesla expand terms of the bulletin to cover all vehicles equipped with fore links.

(Reporting by Akash Sriram in Bengaluru; Editing by Mrigank Dhaniwala and Varun H K)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TRxADE Health, Scienture Complete Business Combination; TRxADE Shares Jump
TRxADE Health, Scienture Complete Business Combination; TRxADE Shares Jump
Jul 26, 2024
11:20 AM EDT, 07/26/2024 (MT Newswires) -- TRxADE Health ( MEDS ) and Scienture said Friday they have completed their all-stock business combination valued at $103 million. Under the deal, TRxADE acquired Scienture's assets in exchange for common stock and non-voting convertible preferred stock and will rebrand as Scienture Holdings and continue to trade on Nasdaq. Scienture stockholders will own...
Apple signs on to voluntary US scheme to manage AI risks, White House says
Apple signs on to voluntary US scheme to manage AI risks, White House says
Jul 26, 2024
WASHINGTON, July 26 (Reuters) - Apple Inc ( AAPL ) has signed U.S. President Joe Biden's voluntary commitments governing artificial intelligence (AI), joining 15 other firms that have committed to ensuring that AI's power is not used for destructive purposes, the White House said on Friday. The original commitments, announced in July 2023, were signed on to by firms including...
Truist Securities on Waste Connections' Outlook
Truist Securities on Waste Connections' Outlook
Jul 26, 2024
11:17 AM EDT, 07/26/2024 (MT Newswires) -- Waste Connections ( WCN ) reported upside second quarter results and raised 2024 guidance primarily due to another active M&A quarter (bought ~$275 million in annual revenue), notes Truist Securities. We think WCN is poised to message another year of outsized margin expansion in 2025 next quarter with easier volume comps and persistent...
Geron's Rytelo Gets NCCN Recommendation for Treatment of Symptomatic Anemia in Myelodysplastic Syndromes
Geron's Rytelo Gets NCCN Recommendation for Treatment of Symptomatic Anemia in Myelodysplastic Syndromes
Jul 26, 2024
11:15 AM EDT, 07/26/2024 (MT Newswires) -- Geron ( GERN ) said Friday that the National Comprehensive Cancer Network updated its guidelines to recommend Rytelo, or imetelstat, as a Category 1 and 2A treatment for symptomatic anemia in lower-risk myelodysplastic syndromes. The Category 1 recommendation is for second-line treatment after Bristol-Myers Squibb's ( BMY ) Reblozyl, or luspatercept, in patients...
Copyright 2023-2026 - www.financetom.com All Rights Reserved